NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球眼內黑色素瘤市場(2021年∼2028年)

Global Intraocular Melanoma Market - 2021-2028

出版商 DataM Intelligence 商品編碼 1008255
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
全球眼內黑色素瘤市場(2021年∼2028年) Global Intraocular Melanoma Market - 2021-2028
出版日期: 2021年05月27日內容資訊: 英文 180 Pages
簡介

眼內黑色素瘤是一種罕見的癌症,發生在眼球中,可導致視力不佳和失明。眼內黑色素瘤的病因尚不清楚,但紫外線是一個危險因素。然而有許多新的治療方法,包括藥物治療,治療選擇正在增加。創新療法的不斷發展正在推動全球眼內黑色素瘤市場的成長。

本報告提供全球眼內黑色素瘤市場調查,彙整市場概要,市場區隔·各地區的市場規模及成長率的變化與預測,新型冠狀病毒感染疾病(COVID-19)的影響分析,市場成長的推動要素及阻礙因素分析,市場機會,價格及貿易趨勢,競爭情形,主要企業簡介等資訊。

目錄

第1章 調查手法和範圍

  • 調查手法
  • 調查的目的和調查範圍

第2章 市場定義和概要

第3章 摘要整理

  • 市場規模·與前一年同期比較成長率:各部位
  • 市場規模·與前一年同期比較成長率:各診斷法
  • 市場規模·與前一年同期比較成長率:各治療法
  • 市場規模·與前一年同期比較成長率:各終端用戶
  • 市場明細:各地區

第4章 市場動態

  • 市場影響要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求

第6章 新型冠狀病毒感染疾病(COVID-19)的影響分析

  • 新型冠狀病毒感染疾病(COVID-19)的影響分析
    • COVID-19前的市場方案
    • 目前市場方案
    • COVID-19後的市場方案
  • COVID-19中的價格趨勢
  • 供需頻譜
  • 政府在COVID-19疫情下的市場相關措施
  • 製造商策略性舉措
  • 總論

第7章 全球眼內黑色素瘤市場:各部位

  • 簡介
    • 市場規模·與前一年同期比較成長率分析:各部位
    • 市場魅力指數:各部位
  • 鞏膜
    • 簡介
    • 市場規模·成長率分析
  • 視網膜
  • 葡萄膜

第8章 全球眼內黑色素瘤市場:各診斷法

  • 簡介
    • 市場規模·與前一年同期比較成長率分析:各治療類型
    • 市場魅力指數:各治療類型
  • 眼檢驗
    • 簡介
    • 市場規模·成長率分析
  • 成像
  • 切片檢查

第9章 全球眼內黑色素瘤市場:各治療法

  • 簡介
    • 市場規模·與前一年同期比較成長率分析:各治療法
    • 市場魅力指數:各治療法
  • 放射治療
    • 簡介
    • 市場規模·成長率分析
  • 雷射治療
  • 外科手術
  • 標靶治療
  • 化療

第10章 全球眼內黑色素瘤市場:各終端用戶

  • 簡介
    • 市場規模·與前一年同期比較成長率分析:各終端用戶
    • 市場魅力指數:各終端用戶
  • 醫院
    • 簡介
    • 市場規模·成長率分析
  • 診療所
  • 門診外科中心

第11章 全球眼內黑色素瘤市場:各地區

  • 簡介
  • 市場規模分析·與前一年同期比較成長率:各地區
  • 市場魅力指數:各地區
  • 北美
    • 簡介
    • 市場動態
    • 市場規模·與前一年同期比較成長率:各部位
    • 市場規模·與前一年同期比較成長率:各診斷法
    • 市場規模·與前一年同期比較成長率:各治療法
    • 市場規模·與前一年同期比較成長率:各終端用戶
    • 市場規模·與前一年同期比較成長率:各國
  • 歐洲
    • 簡介
    • 市場動態
    • 市場規模·與前一年同期比較成長率:各部位
    • 市場規模·與前一年同期比較成長率:各診斷法
    • 市場規模·與前一年同期比較成長率:各治療法
    • 市場規模·與前一年同期比較成長率:各終端用戶
    • 市場規模·與前一年同期比較成長率:各國
  • 南美
    • 簡介
    • 市場動態
    • 市場規模·與前一年同期比較成長率:各部位
    • 市場規模·與前一年同期比較成長率:各診斷法
    • 市場規模·與前一年同期比較成長率:各治療法
    • 市場規模·與前一年同期比較成長率:各終端用戶
    • 市場規模·與前一年同期比較成長率:各國
  • 亞太地區
    • 簡介
    • 市場動態
    • 市場規模·與前一年同期比較成長率:各部位
    • 市場規模·與前一年同期比較成長率:各診斷法
    • 市場規模·與前一年同期比較成長率:各治療法
    • 市場規模·與前一年同期比較成長率:各終端用戶
    • 市場規模·與前一年同期比較成長率:各國
  • 中東·非洲
    • 簡介
    • 市場動態
    • 市場規模·與前一年同期比較成長率:各部位
    • 市場規模·與前一年同期比較成長率:各診斷法
    • 市場規模·與前一年同期比較成長率:各治療法
    • 市場規模·與前一年同期比較成長率:各終端用戶

第12章 競爭情形

  • 競爭模式
  • 市場定位/股票分析
  • 合併·收購分析

第13章 企業簡介

  • Astra Zeneca plc
    • 企業概要
    • 產品系列
    • 主要的焦點
    • 財務形勢
  • Eli Lilly & Co.
  • Pfizer, Inc.
  • Novartis AG
  • Spectrum Pharmaceuticals, Inc
  • Merck
  • Roche
  • Amgen
  • Bayer
  • Spectrum Pharmaceuticals, Inc

第14章 關於DataM Intelligence

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Market Overview

The global intraocular melanoma market size was valued US$ XX billion in 2019 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Intraocular melanoma is rare cancer that develops inside the eye. It creates melanocytes (cells that generate pigment or color) to grow out of control. The disorder can lead to vision changes or loss. Intraocular melanoma usually attacks the middle part of the eye called the uvea. The uvea is among the sclera (outer white part of the eye), including the retina (inner part of the eye that processes light and controls vision).

Vision loss is expected with intraocular melanoma. The amount of vision loss depends on the size of the melanoma. Long-standing eye melanomas may cause comprehensive loss of vision. Intraocular melanoma is the most common type of eye cancer in adults. But the condition is infrequent. Healthcare providers diagnose about 2,500 people in the U.S. with intraocular melanoma each year.

The cause of intraocular melanoma is unclear, but UV light is a risk factor. However, many new treatments such as pharmacotherapy have increased the treatment options with the high risk of infection recurrence among patients.

Market Dynamics

The intraocular melanoma market growth is driven by the increasing development of innovative treatment options in intraocular melanoma treatment are expected to drive growth of the global intraocular melanoma market during the forecast period.

Innovative treatment options in intraocular melanoma treatments will drive the market growth

Advancements in growing innovative treatment options in intraocular melanoma therapies such as understanding the molecular features of the intraocular tumor into genetic alternations and mutations studies in patients and novel treatments based on inhibition mechanism of interpretation of growth factor receptors such as c-Met and c-Kit are being investigated to deliver better treatment options for patients.

Moreover, rampant research about melanoma, increasing incidence burden of intraocular melanoma, and developing several clinical trials for new methods, in turn, is expected to support the growth of the intraocular melanoma market over the forecasted period. For instance, as per the American Society of Clinical Oncology, in 2015, around 3,540 adults (2,130 men and 1,410 women) in the U.S. were diagnosed with primary intraocular cancer. According to the American Academy of Ophthalmology (AAO), 2014 data findings, uveal melanoma is the most generally diagnosed primary intraocular malignancy in adults, with 90% of uveal melanoma including the choroid 5% affecting the ciliary body, and 5% developing in the iris. Additionally, intraocular melanoma is 5%-10% of all melanomas. Additionally, according to the American Academy of Ophthalmology (AAO), 2014 data findings, the incidence of intraocular melanoma is more eminent among the fairly pigmented groups while exceedingly lower among the Asian and African populations.

Rapid research and development activities associated with melanomac is driving the market growth

Rapid research and development activities associated with melanoma, coupled with the increasing burden of intraocular melanoma, and an increasing number of clinical trials for new treatments, are expected to drive the growth of the global intraocular melanoma treatment market shortly. The prevalence of eye cancer has increased by 25% in the U.K. Additionally, rising healthcare expenditures and increasing research and development investments by the market's significant players boost the market growth.

Side effects associated with certain medications coupled with high cost of cancer treatment

High cost and adverse side effects associated with the treatment of intraocular melanoma coupled with poor reimbursement infrastructure are expected to hamper the growth of the intraocular melanoma market in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has had an unprecedented impact on the National Health Service in the United Kingdom. The UK Ocular Oncology Services evaluated the impact on intraocular melanoma care in the UK. All four adult Ocular Oncology centers participated in a multicentre retrospective review comparing uveal melanoma referral patterns and treatments in 4 months during the national lockdown and first wave of the COVID-19 pandemic in 2020 with corresponding periods in the previous two years. During the national lockdown, referral numbers and confirmed intraocular melanoma cases reduced considerably, equalling 120 fewer diagnosed uveal melanoma cases than the previous two years. As the COVID-19 pandemic continues to mount pressure and reveal its hidden impact on intraocular melanoma market in the forecast period.

Segment Analysis

By diagnosis, the intraocular melanoma market is classified into eye exam, imaging, biopsy.

Biopsy segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)

A biopsy is a method to remove a piece of tissue or a unit of cells of the body to be examined in a laboratory. If a patient is experiencing specific symptoms doctor has identified an area of concern, it may undergo a biopsy to determine whether the patient has cancer or some other condition. Biopsies are most usually done to examine for cancer. But biopsies can help recognize many other conditions. In some cases, a biopsy of normal-appearing tissue may be done. A biopsy can help check for eye cancer spread or denial of a transplanted organ. There are various kinds of biopsies. Approximately all of them involve using a sharp tool to remove a small amount of tissue.

More invasive biopsies may be done in a hospital, a surgery center, or a specialized doctor's office. You would make a separate appointment for the biopsy. In most cases, sedating and pain relief medicines are given, reducing any discomfort. You likely won't be able to drive after receiving these medicines. Sometimes, a biopsy may be useful to check for certain gene mutations (changes) that can predict outcomes (prognosis) as well as help choose targeted drugs for eye cancer. Also, certain eye melanomas can spread for many years before they are diagnosed so doing a biopsy of a worrisome area early may be helpful.

On the basis of therapy, the the intraocular melanoma market is classified into targeted therapy radiation therapy, immunotherapy, chemotherapy.

The chemotherapy segment are expected to dominate the Intraocular Melanoma market during the forecast period

Chemotherapy is the use of anti-cancer medications used to treatment of cancerous cells. Chemotherapy has been done for many years and is one of the most prevalent cancer treatments. In most instances, chemotherapy works by preventing the cancer cell's ability to grow or multiply. Several groups of medications work in many ways to fight cancer cells. Chemotherapy may be used alone for some types of cancer or in sequence with other treatments such as radiation or surgery. Often, a mixture of chemotherapy drugs is used to fight particular cancer. Some chemotherapy drugs are given in a specific amount depending on the type of cancer used for treatment.

While chemotherapy can be quite efficient in treating specific cancers, chemotherapy medications reach all body parts. The carcinoma cells that cause may be many side effects during therapy.

Geographical Analysis

North America region holds the largest market share in the global Intraocular Melanoma market

North America region is dominating the global intraocular melanoma market accounted for the largest market share in 2020, owing to the increasing incidence of intraocular melanoma in the region. For instance, as per the National Cancer Institute data in 2016, the mean age-adjusted percentage of intraocular melanoma in the U.S. is around 4.3-8.4 new cases per million people per year.

Several research organizations in the countries are engaged in raising funding for a study to develop intraocular melanoma therapy. For instance, the Melanoma Research Foundation, a Washington-based organization assigned to receiving adequate treatment in various types of melanoma, raised around US$ 1.2 million for intraocular melanoma and its treatment from 2012. Furthermore, in April 2018, the Ocular Melanoma Foundation, in collaboration with the American Association for Cancer Research, offered research funding of US$ 150,000 to researchers at the Casey Eye Institute to study advertising hybrid tumor cells as a prognostic biomarker for intraocular melanoma.

Competitive Landscape

The intraocular melanoma market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Astra Zeneca plc, Eli Lilly & Co., Pfizer, Inc. Novartis AG, and Spectrum Pharmaceuticals, Inc., Merck, Roche, Amgen, Bayer, and Spectrum Pharmaceuticals, Inc among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Intraocular Melanoma market globally.

Pfizer Inc.

Overview: Pfizer Inc. (Pfizer), incorporated on June 2, 1942, is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines that improve patients' lives. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology and rare diseases. EH includes legacy brands, branded generics, generic sterile injectable products, and biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. The Company sold its products in over 125 countries.

Product Portfolio: The Company's portfolio comprised of include internal medicine, vaccines, oncology, inflammation and immunology and rare diseases and others.

Why Purchase the Report?

  • Visualize the composition of the intraocular melanoma market segmentation by site, therapy, diagnosis, and end user highlighting the key commercial assets and players.
  • Identify commercial opportunities in intraocular melanoma market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of intraocular melanoma market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global intraocular melanoma market report would provide an access to an approx. 51 market data table, 61 figures and 200 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Intraocular Melanoma Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Intraocular Melanoma Market - Market Definition and Overview

3. Global Intraocular Melanoma Market - Executive Summary

  • 3.1. Market Snippet by Site
  • 3.2. Market Snippet by Therapy
  • 3.3. Market Snippet by Diagnosis
  • 3.4. Market Snippet by End User
  • 3.5. Market Snippet by Region

4. Global Intraocular Melanoma Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovative treatment options in intraocular melanoma treatments will drive the market growth
      • 4.1.1.2. The rising burden of liver cancer across the globe is driving the market growth
    • 4.1.2. Restraints:
      • 4.1.2.1. Rapid research and development activities associated with melanoma is driving the market growth
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Intraocular Melanoma Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Unmet Needs

6. Global Intraocular Melanoma Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Intraocular Melanoma Market - By Site

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Site Segment
    • 7.1.2. Market Attractiveness Index, By Site Segment
  • 7.2. Sclera*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Retina
  • 7.4. Uvea

8. Global Intraocular Melanoma Market - By Diagnosis

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis
    • 8.1.2. Market Attractiveness Index, By Diagnosis
  • 8.2. Eye Exam*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Imaging
  • 8.4. Biopsy

9. Global Intraocular Melanoma Market - By Therapy

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy
    • 9.1.2. Market Attractiveness Index, By Therapy
  • 9.2. Radiation Therapy*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Laser Therapy
  • 9.4. Surgery
  • 9.5. Targeted therapy
  • 9.6. Chemotherapy

10. Global Intraocular Melanoma Market - By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 10.1.2. Market Attractiveness Index, By End User Segment
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 10.3. Clinics
  • 10.4. Ambulatory Surgical Centers

11. Global Intraocular Melanoma Market - By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Site
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Site
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Distribution Channel
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Site
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Site
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Site
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnosis
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Global Intraocular Melanoma Market - Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Global Intraocular Melanoma Market- Company Profiles

  • 13.1. Astra Zeneca plc*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Eli Lilly & Co.
  • 13.3. Pfizer, Inc.
  • 13.4. Novartis AG
  • 13.5. Spectrum Pharmaceuticals, Inc
  • 13.6. Merck
  • 13.7. Roche
  • 13.8. Amgen
  • 13.9. Bayer
  • 13.10. Spectrum Pharmaceuticals, Inc

LIST NOT EXHAUSTIVE

14. Global Intraocular Melanoma Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us